By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.

Contact Information

Website: www.verupharma.com
Email: veruinvestor@verupharma.com
Main Phone: +1 305 509-6897
Address: 48 NW 25th Street
Address 2: Suite 102
State: FL
City / Town: Miami
Country: US
Postal Code: 33137

Issuer Information

Exchange: NSC
CEO: Mitchell S. Steiner
Employees: 339
NAICS: Research and Development in Nanotechnology(541713)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A